Where DX CEOs Come From
Executive SummaryThe CEOs that took diagnostics companies public in the 1990s came from firms big and small, with much experience or none at all. The energy they bring to these jobs may matter more than particular skill sets.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.